Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duragesic in Pediatric Chronic Pain
NCT00271466Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Feb 2000
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, open-label, single-arm trial of fentanyl in chronic pain, sponsored by Johnson & Johnson. Primary endpoints: Incidence and severity of adverse events and Vital sign measurements. Started Feb 2000; status: completed.
02
Drugs
fentanyl
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT00271466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00271466.